<div id="readability-page-1"><div><div><div><p>U.S. stocks closed higher on Monday, with the Dow Jones Industrial Average inching up 0.08% to 42,305.48, the S&amp;P 500 advancing 0.4% to 5,935.94, and the Nasdaq climbing nearly 0.7% to 19,242.61.</p><p>These are the top stocks that gained the attention of retail traders and investors throughout the day:</p></div><p><strong>Applied Digital Corp</strong> <span>APLD</span></p><p>Applied Digital’s shares surged by 48.46%, closing at $10.14. The stock hit an intraday high of $10.54 and a low of $8.03, with a 52-week range of $3.01 to $12.48. The shares rose nearly 3.5% in the after-hours trading. The company announced long-term lease agreements with CoreWeave Inc., spanning approximately 15 years. These agreements will provide 250 megawatts of critical IT load to support CoreWeave’s AI and high-performance computing infrastructure at Applied Digital’s North Dakota data center.</p><p><strong>Meta Platforms Inc.</strong> <span>META</span></p><p>Meta Platforms saw a 3.62% increase, closing at $670.90. The stock’s intraday high was $673.26, with a low of $644.26, and a 52-week range of $442.65 to $740.89. The company is reportedly preparing to launch a fully automated ad creation system powered by AI by the end of 2026. This initiative is part of CEO <strong>Mark Zuckerberg’s</strong> strategy to enhance AI capabilities and revolutionize ad creation and delivery.</p><p><strong>Alphabet Inc.</strong> <span>GOOGL</span> <span>GOOG</span></p><p>Alphabet’s Class A stock declined by 1.6%, closing at $169.03. The stock reached a high of $169.87 and a low of $167.39, with a 52-week range of $140.53 to $207.05. The Company’s Class C shares closed 1.4% lower at $170.37. Despite concerns about Google Search’s value, Goldman Sachs analysts believe Alphabet is strategically positioned for the AI era, particularly with its Google AI and YouTube offerings.</p><p><strong>Lyra Therapeutics, Inc.</strong> <span>LYRA</span></p><p><strong>Latest Startup Investment Opportunities</strong>:</p><div><div><div><div><div><div><ul><li><div><div><p><span><img src="https://imageproxy.pbkrs.com/https://cdnwp-s3.benzinga.com/wp-content/uploads/2025/01/06125138/IMG_5682-edited.jpeg/query-YXV0bz13ZWJwJmF1dG89d2VicCZkcHI9MSZkcHI9MiZvcHRpbWl6ZT1tZWRpdW0md2lkdGg9MTA4MD9vcHRpbWl6ZT1tZWRpdW0md2lkdGg9Mzg0MA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1000" height="563" original-src="https://imageproxy.pbkrs.com/https://cdnwp-s3.benzinga.com/wp-content/uploads/2025/01/06125138/IMG_5682-edited.jpeg/query-YXV0bz13ZWJwJmF1dG89d2VicCZkcHI9MSZkcHI9MiZvcHRpbWl6ZT1tZWRpdW0md2lkdGg9MTA4MD9vcHRpbWl6ZT1tZWRpdW0md2lkdGg9Mzg0MA"/></span></p></div><div><div><p><span></span></p><div><div><div><p><span>Min. Investment</span><span>$1,000</span></p><p><span>Industry</span><span>AI</span></p></div></div></div>Get Offer <p></p></div></div></div></li><li><div><div><p><span><img src="https://imageproxy.pbkrs.com/https://cdnwp-s3.benzinga.com/wp-content/uploads/2025/01/12011752/Screenshot-2025-01-11-at-10.17.30%E2%80%AFPM.jpg/query-YXV0bz13ZWJwJmRwcj0yJm9wdGltaXplPW1lZGl1bSZ3aWR0aD0zODQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="7680" height="4130" original-src="https://imageproxy.pbkrs.com/https://cdnwp-s3.benzinga.com/wp-content/uploads/2025/01/12011752/Screenshot-2025-01-11-at-10.17.30%E2%80%AFPM.jpg/query-YXV0bz13ZWJwJmRwcj0yJm9wdGltaXplPW1lZGl1bSZ3aWR0aD0zODQw"/></span></p></div><div><div><p><span></span></p><div><div><div><p><span>Min. Investment</span><span>$974</span></p><p><span>Industry</span><span>Tech</span></p></div></div></div>Get Offer <p></p></div></div></div></li></ul></div></div></div></div></div></div><p>Lyra Therapeutics experienced a remarkable 310.75% jump, closing at $20.25. The stock’s intraday high was $37.50, with a low of $8.65, and a 52-week range of $3.81 to $37.50. The surge followed the release of positive results from the ENLIGHTEN 2 Phase 3 trial of LYR-210, which showed significant improvement in treating Chronic Rhinosinusitis. The stock gained 4.9% in after-hours trading.</p><p><strong>Tesla Inc.</strong> <span>TSLA</span></p><p>Tesla’s shares fell by 1.09%, closing at $342.69. The stock recorded an intraday high of $348.02 and a low of $333.33, with a 52-week range of $167.42 to $488.54. The company is facing increased competition from Chinese electric vehicle makers, including BYD, Li Auto, Nio, and Xpeng, all of which reported strong delivery numbers for May.</p><p><strong>Benzinga’s Edge Stock</strong> <strong>Rankings</strong> show that Meta has a positive Price Trend in the Short, Medium and Long terms. Here is how the stock is ranked on other metrics.</p><p><em>Photo Courtesy: Billion Photos on Shutterstock.com</em></p><p><em>Prepare for the day’s trading with top premarket movers and news by Benzinga.</em></p><ul> <li><strong>Cathie Wood Sells Tesla Stock As Chinese Rivals Gain Ground — Ark Dumps Palantir Amid Privacy Concerns</strong></li> </ul><p>This story was generated using Benzinga Neuro and edited by <u>Shivdeep Dhaliwal</u></p></div></div></div>

LYRA

APLD

GOOGL

GOOG

<p>U.S. stocks closed higher on Monday, with notable movements in several stocks. Applied Digital Corp surged 48.46% after announcing long-term lease agreements with CoreWeave. Meta Platforms rose 3.62% as it prepares to launch an AI-driven ad creation system. Alphabet's Class A shares fell 1.6%, but analysts remain optimistic about its AI positioning. Lyra Therapeutics jumped 310.75% following positive trial results for LYR-210. Tesla's shares declined 1.09% amid rising competition from Chinese EV makers.</p>

- U.S. stocks closed higher on Monday, with the Dow Jones up 0.08%, S&P 500 rising 0.4%, and Nasdaq increasing nearly 0.7%.  
- Applied Digital Corp saw a significant surge of 48.46% after announcing long-term lease agreements, while Meta Platforms increased by 3.62% amid plans for an AI-driven ad system.  
- Conversely, Alphabet's Class A stock declined by 1.6%, and Tesla shares fell by 1.09% due to rising competition from Chinese electric vehicle manufacturers.

Applied Digital Corp, Meta Platforms, Alphabet, Lyra Therapeutics, Tesla: Why These 5 Stocks Are On Investors' Radars Today